-17.19% percent quarterly performance for Terns Pharmaceuticals Inc (TERN) is not indicative of the underlying story

On Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) was 0.54% jump from the session before ,before settling in for the closing price of $5.51. A 52-week range for TERN has been $3.26 – $14.04.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -20.00%. When this article was written, the company’s average yearly earnings per share was at -9.26%. With a float of $40.04 million, this company’s outstanding shares have now reached $64.58 million.

Considering the fact that the conglomerate employs 66 people, you should pay attention to its efficiency factor.

Terns Pharmaceuticals Inc (TERN) Insider Activity

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Terns Pharmaceuticals Inc stocks. The insider ownership of Terns Pharmaceuticals Inc is 38.07%, while institutional ownership is 76.32%. The most recent insider transaction that took place on Apr 03 ’24, was worth 856,009. In this transaction 10% Owner of this company sold 138,066 shares at a rate of $6.20, taking the stock ownership to the 268,573 shares. Before that another transaction happened on Apr 02 ’24, when Company’s 10% Owner sold 101,480 for $6.65, making the entire transaction worth $674,842. This insider now owns 272,722 shares in total.

Terns Pharmaceuticals Inc (TERN) Earnings and Forecasts

Going through the last 3-months fiscal report unveiled on the 12/30/2023, it has been observed that the corporation posted -$0.29 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.29) by $0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -9.26% per share during the next fiscal year.

Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators

You can see what Terns Pharmaceuticals Inc (TERN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 22.39.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.27, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.40 in one year’s time.

Technical Analysis of Terns Pharmaceuticals Inc (TERN)

Compared to the last year’s volume of 0.89 million, its volume of 1.17 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 9.50%. Additionally, its Average True Range was 0.57.

During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 39.85%, which indicates a significant increase from 12.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 87.67% in the past 14 days, which was higher than the 87.54% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.69, while its 200-day Moving Average is $6.13. Nevertheless, the first resistance level for the watch stands at $5.75 in the near term. At $5.96, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.13. If the price goes on to break the first support level at $5.37, it is likely to go to the next support level at $5.20. Should the price break the second support level, the third support level stands at $4.99.

Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats

There are 64,652K outstanding shares of the company, which has a market capitalization of 358.16 million. As of now, sales total 0 K while income totals -90,210 K. Its latest quarter income was 0 K while its last quarter net income were -21,020 K.